The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 10.1% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 87%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (22 analysts) rates it buy, with a mean price target of $124. Insiders have been net sellers over the past quarter.
Cisco
CSCO · a US exchange · USD · Market cap $430.4B · 86,200 employees
Cisco Systems, Inc.
PASS · Titan Ethical · score 81.4At the last full screen
2026-09-08
Screened 2026-09-08 · the tape above runs as of 21:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its distribution label.
Cisco holds its Distribution at $109.17. Consolidating, no directional conviction, held for 1 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 1 days |
| Price at the screen | $109.17 |
| Valuation | 32.78 trailing · 19.49 forward price to earnings |
| Values screen | PASS · score 81.4 |
| Beta | 0.99 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 22.97% | Below 33% | Interest-bearing debt is just 23.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 6.35% | Below 33% | Cash held in interest-bearing accounts and securities is 6.3% of assets, under the one-third limit. | Pass |
| Receivables | 12.30% | Below 49% | Money owed to the company is 12.3% of assets, under the 49% limit. | Pass |
| Revenue purity | 1.77% | Below 5% | Only 1.8% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Conscience OverlayThe quantitative screen above is arithmetic and this name passes it. Separately, community boycott lists cite this company: Cited by BDS movement for providing networking and surveillance technology used by Israeli security forces. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
The Fair Value Range
Our framework reads OVERVALUED: it trades at roughly a 29% discount to our $140.33 fair value, moderate competitive moat, 17.60% revenue growth.
Fair value range in USD, drawn from the 2026-09-08 screen. The gold marker is the market price at the same screen. A 28.5% margin of safety to the base estimate.
Third-party analyst targets: 24 covering, consensus Buy. The average target sits +24% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-08 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsTech Titan Undervalued Despite Market Caution
Imagine the internet as a bustling city; every building, every streetlight, every traffic signal runs on Cisco's infrastructure – that's the scale of its influence. Cisco's digital backbone spans continents, and with a forward P/E of 19.8x, it looks like a steal in today's tech-heavy market. With 18% revenue growth and a 21% profit margin, Cisco isn't just growing; it's doing so efficiently. Why it stands out is its balance of innovation and stability, a combination rare in the tech world, reflected in its 27% ROE and a moderate moat that shields it from competitors.
However, despite this robust performance, the market has priced Cisco at $109.59, under our fair value of $139.54, suggesting a margin of safety of +27%. While 22 analysts have a consensus buy rating with a median target of $135, the label of 'overvalued' might spook some investors. Yet, considering Cisco's ethical pass and its steady performance metrics, the risk seems more a reflection of market jitters than company fundamentals.
In conclusion, while the market may be cautious, the numbers tell a different story. Cisco's ethical and financial performance are robust, and for those seeking stability with room for growth, it presents a compelling case. Analysis, not advice.
| Forward P/E | 19.5xfairly priced for its growth rate |
| Trailing P/E | 32.8xa premium valuation |
| EPS, trailing | 3.33 |
| EPS, forward | 5.60 |
| Revenue growth | +17.6%steady growth |
| Profit margin | 21.0%healthy profit margins |
| Return on equity | 27.3%an exceptional return on shareholder capital |
| FCF yield | 2.60% |
| Dividend yield | 1.45% |
| Debt to equity | 0.62moderate, manageable leverage |
| Current ratio | 0.93below 1: short-term bills exceed liquid assets |
| Beta | 0.99steadier than the market |
| Short interest, float | 0.01% |
| 52-week range | 66.13 - 130.37 |
| Moat | MODERATE |
| Market cap | $430.4B |
| Employees | 86,200 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeCSCO trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 87%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (22 analysts) rates it buy, with a mean price target of $124. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 87%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (22 analysts) rates it buy, with a mean price target of $124. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 87%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (22 analysts) rates it buy, with a mean price target of $124. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 87%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (22 analysts) rates it buy, with a mean price target of $124. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 87%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (22 analysts) rates it buy, with a mean price target of $124. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 6.4% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 87%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (22 analysts) rates it buy, with a mean price target of $124. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 87%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (22 analysts) rates it buy, with a mean price target of $124. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 6.1% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 87%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (22 analysts) rates it buy, with a mean price target of $124. Insiders have been net sellers over the past quarter.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 87%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (22 analysts) rates it buy, with a mean price target of $124. Insiders have been net sellers over the past quarter.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Cisco (CSCO) Leans on Splunk to Broaden Its Share of Enterprise AI Spending. It Faces a Big Test Insider Monkey · 1d ago
- IBM Has Raised Its Dividend for 31 Years. Inflation Is Still Winning 24/7 Wall St. · 1d ago
- Did SMCI Stock Just Rise For The Wrong Reason? Trefis · 2d ago
- Cisco Drops 8% in 3 Months: Should You Buy the Stock on the Dip? Zacks · 2d ago
- Can Hewlett Packard Enterprise Stock Keep Running On Orders It Cannot Ship? Trefis · 2d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-14 | Subaiya Thimaya K. | EVP, Operations | S - Sale | 312 | $34,376 |
| 2026-09-14 | Tuszik Oliver | EVP, Global Sales | S - Sale | 680 | $74,922 |
| 2026-09-11 | Patterson Mark | EVP, CFO | S - Sale | 1,795 | $195,422 |
| 2026-05-22 | Robbins Charles | Chair, CEO | Sale | 21,400 | $2,568,584 |
| 2026-05-15 | Tuszik Oliver | EVP, Global Sales | Sale | 2,761 | $316,438 |
| 2026-05-15 | Stahlkopf Deborah L | EVP, GC | Sale | 6,586 | $772,580 |
| 2026-05-15 | Patterson Mark | EVP, CFO | Sale | 5,512 | $646,485 |
| 2026-05-15 | Patel Jeetendra I | Pres, CPO | Sale | 7,169 | $840,781 |
| 2026-03-20 | Patterson Mark | EVP, CFO | Sale | 4,892 | $381,450 |
| 2026-03-17 | Stahlkopf Deborah L | EVP, GC | Sale | 7,981 | $634,513 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-08-24 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-08-24 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-08-24 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-08-03 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-08-03 | Ro Khanna | Democrat | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $98.72 | +20.6% | · | $1,206 | +20.6% |
| 2 months | $82.22 | +44.8% | · | $1,448 | +44.8% |
| 3 months | $77.32 | +54.0% | $0.42 | $1,546 | +54.6% |
| 6 months | $78.42 | +51.9% | $0.83 | $1,529 | +52.9% |
| 1 year | $63.68 | +87.0% | $1.65 | $1,896 | +89.6% |
| 2 years | $43.51 | +173.7% | $3.26 | $2,812 | +181.2% |
| 3 years | $45.71 | +160.6% | $4.83 | $2,711 | +171.1% |
| 5 years | $47.47 | +150.9% | $7.85 | $2,674 | +167.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever CSCO does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.